Trial · NCT01652040
Resistance Training and Testosterone After Spinal Cord Injury
NCT01652040, Phase 2, Phase 3, Completed, VA Office of Research and Development; results first posted 2018-05-03
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Resistance Training and Testosterone After Spinal Cord Injury. Trials, record NCT01652040. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01652040
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Resistance Training and Testosterone After Spinal Cord Injury
- NCT number
- NCT01652040
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 26 participants, actual
- Lead sponsor
- VA Office of Research and Development
- Conditions
- Spinal Cord Injury
- Interventions
- Resistance Training and Testosterone Patches, Testosterone Patches
- First posted
- 2012-07-27
- Last updated
- 2018-05-03
- Results first posted
- 2018-05-03
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Body Composition | 16 weeks | Changes in body composition fat mass |
| Secondary | Metabolic Profile | 16 weeks | Basal Metabolic Rate |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Body Composition | 16 weeks | percentage of fat mass | MEAN | |
| SECONDARY | Metabolic Profile | 16 weeks | kcal/day | MEAN |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Body Composition | RT+Tp | Baseline | 31.84 | Standard Deviation 10.7 | percentage of fat mass |
| Body Composition | Testosteroe Replacement Patches (Tp) | Baseline | 33.4 | Standard Deviation 9 | percentage of fat mass |
| Body Composition | RT+Tp | Post-Intervention (After 16 weeks) | 30.75 | Standard Deviation 10.3 | percentage of fat mass |
| Body Composition | Testosteroe Replacement Patches (Tp) | Post-Intervention (After 16 weeks) | 32.12 | Standard Deviation 9 | percentage of fat mass |
| Metabolic Profile | RT+Tp | Baseline | 1525 | Standard Deviation 261 | kcal/day |
| Metabolic Profile | Testosterone Replacement Patches (Tp) | Baseline | 1491 | Standard Deviation 177 | kcal/day |
| Metabolic Profile | RT+Tp | Post-Intervention (After 16 weeks) | 1665 | Standard Deviation 243 | kcal/day |
| Metabolic Profile | Testosterone Replacement Patches (Tp) | Post-Intervention (After 16 weeks) | 1502 | Standard Deviation 327 | kcal/day |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | RT+Tp | 13 | |
| Overall Study | STARTED | Testosterone Replacement Patches (Tp) | 13 | |
| Overall Study | COMPLETED | RT+Tp | 11 | |
| Overall Study | COMPLETED | Testosterone Replacement Patches (Tp) | 11 | |
| Overall Study | NOT COMPLETED | RT+Tp | 2 | |
| Overall Study | NOT COMPLETED | Testosterone Replacement Patches (Tp) | 2 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | RT+Tp | 0 | 13 |
| Total, all-cause mortality | Testosterone Replacement Patches (Tp) | 0 | 13 |
| Total, other adverse events | RT+Tp | 0 | 13 |
| Total, other adverse events | Testosterone Replacement Patches (Tp) | 0 | 13 |
| Total, serious adverse events | RT+Tp | 0 | 13 |
| Total, serious adverse events | Testosterone Replacement Patches (Tp) | 0 | 13 |
Source ClinicalTrials.gov
Papers25
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| RT+Tp vs Testosterone Replacement Patches (Tp): deaths from any cause | Trial comparisons |
| RT+Tp vs Testosterone Replacement Patches (Tp): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01652040
GET https://conductscience.org/api/trials/v1/NCT01652040/papers?page=2